Drug Marketing Techniques May Be Risking Patient Safety
Posted Dec 07 2008 12:09pm
With new drugs being reviewed by regulatory agencies and then released onto the market faster than ever before, patients’ safety is being compromised, warns a study published on bmj.com today.
Dr David Kao from the University of Colorado Health Sciences Center, argues that while drug regulatory bodies are under pressure to make new drugs available more quickly, there are concerns that the deadlines for approving drugs have shifted the focus away from safety.
Kao reviews trends in drug approval times in the United States, and suggests how drug marketing techniques could be used to improve the way new drugs are monitored.
Previous research has shown that drugs approved in the US during the two months before the mandated deadline were more likely to be withdrawn for safety reasons or to carry a warning.
With new drugs being reviewed by regulatory agencies and then released onto the market faster than ever before, patients’ safety is being compromised, warns a study published on bmj.com today.
Dr David Kao from the University of Colorado Health Sciences Center, argues that while drug regulatory bodies are under pressure to make new drugs available more quickly, there are concerns that the deadlines for approving drugs have shifted the focus away from safety.
Kao reviews trends in drug approval times in the United States, and suggests how drug marketing techniques could be used to improve the way new drugs are monitored.
Previous research has shown that drugs approved in the US during the two months before the mandated deadline were more likely to be withdrawn for safety reasons or to carry a warning.
Read more…..